Ledger.Open graph →
SEC Form D · filed November 13, 2023

SLAM BioTherapeutics, Inc

Offering
$20.0M
Sold
$7.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
THOUSAND OAKS, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Steve Pazol · Thousand Oaks, CADirectorRichard Heinick · Columbus, OHExec · DirectorMark Hagler · Thousand Oaks, CADirectorSteve Pazol · Thousand Oaks, CADirectorRichard Heinick · Columbus, OHExec · DirectorMark Hagler · Thousand Oaks, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗